2024 Fall Conference | C15 - Chronic Inflammatory Demyelinating Polyneuropathy

Date Saturday 10/26/24

Time 10:00 AM - 11:30 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Kelly G. Gwathmey, MD

Topic(s) Autoimmune Neurology, Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should be able to describe the typical and atypical presentations of CIDP; understand the diagnostic evaluation of CIDP, including key electrodiagnostic features, and other supportive diagnostic studies; be able to identify CIDP mimics and diagnostic pitfalls; and understand both the current therapeutic approach to CIDP as well as the evolving treatment landscape.

This program is supported in part by an educational grant from argenx US Inc.

CME Available 1.50 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
10:00 AM - 10:40 AM PDT	Speaker	The Clinical Presentation and Diagnosis of CIDP Kelly G. Gwathmey, MD
10:40 AM - 11:20 AM PDT	Speaker	The Therapeutic Approach to CIDP Christyn M. Edmundson, MD
11:20 AM - 11:30 AM PDT	Speaker	Questions and Answers Kelly G. Gwathmey, MD, Christyn M. Edmundson, MD

Faculty Disclosures
Kelly G. Gwathmey, MD	Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Christyn M. Edmundson, MD	Dr. Edmundson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Dr. Edmundson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Edmundson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Edmundson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Edmundson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Edmundson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.

��ɫ��

��ɫ��